BusinessNewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod ProgramBy Nasdaq OMXNov 2, 2017, 12:02 PM UTC
BusinessAnthera Pharmaceuticals Announces Presentation of Blisibimod Lupus Research at the American Society of Nephrology Annual MeetingBy Nasdaq OMXNov 1, 2017, 9:00 PM UTC
BusinessBioStem Technologies, Inc. Files “Issuer Company-Related Action Notification” with the Financial Industry Regulatory Authority, Requesting Name and Symbol Change to BioBlue TechnologiesBy Nasdaq OMXNov 1, 2017, 4:26 PM UTC
BusinessCascadian Therapeutics to Report Third Quarter 2017 Financial Results on November 8, 2017By Nasdaq OMXNov 1, 2017, 1:19 PM UTC
BusinessMacroGenics to Present Phase 1 Data on Flotetuzumab, a CD123 x CD3 DART® Molecule, at 59th Annual ASH MeetingBy Nasdaq OMXNov 1, 2017, 1:05 PM UTC
BusinessEyeGate Appoints Mike Garanzini as Chief Commercial Officer to Develop and Implement Global Launch StrategyBy Nasdaq OMXNov 1, 2017, 12:30 PM UTC
BusinessCatalyst Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9th, 2017By Nasdaq OMXNov 1, 2017, 12:03 PM UTC
